Related Experiment Video

Updated: Jun 2, 2026

Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
07:01

Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment

Published on: September 20, 2020

Drug trials for older people

Richard I Lindley1

  • 1George Institute for Global Health, Sydney, Australia. richard.lindley@sydney.edu.au

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|May 7, 2011
PubMed

Insights

As the global population ages, drug trials must include older adults and frail individuals to ensure medications are safe and effective for everyone. New research is needed to bridge evidence-practice gaps in geriatric pharmacotherapy.

Area of Science:

  • Gerontology
  • Clinical Pharmacology
  • Evidence-Based Medicine

Background:

  • The global population is experiencing unprecedented aging.
  • Over a billion older adults are projected within decades.
  • Current drug trials inadequately represent older populations, leading to evidence-practice gaps.

Purpose of the Study:

  • To highlight the need for inclusive drug trial criteria.
  • To advocate for the inclusion of older adults and frail individuals in clinical studies.
  • To address the lack of evidence regarding drug efficacy and safety in the aging population.

Main Methods:

  • Review of current practices in randomized controlled trials (RCTs).
  • Identification of age and frailty exclusion criteria in existing studies.
  • Proposal for modifications in future RCT design.

Main Results:

  • Significant evidence-practice gaps exist due to the exclusion of older and frail individuals from drug trials.
  • Inappropriate age limits and exclusion of frail participants are common in RCTs.
  • Current drug efficacy and safety data are insufficient for the aging demographic.

Conclusions:

  • Abolish age limits in new randomized controlled trials.
  • Routinely measure frailty in older adult participants.
  • Conduct new RCTs to validate treatment effectiveness and safety in elderly and frail populations.
  • Prioritize research ensuring drug efficacy for older individuals.

More Related Videos

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...